Chemours, DuPont, Corteva Settle North Carolina PFAS Claims for US$455 Million

RegulationCorporate Action
โดย Simply Wall St·US·Read original
Summary · why it matters

Chemours, DuPont, and Corteva reached a settlement with North Carolina and 11 nearby local entities on September 9, 2026, agreeing to pay US$455 million over 15 years to resolve PFAS-related claims tied to Chemours' Fayetteville Works facility and other contamination issues. The agreement clears a significant portion of Chemours' legacy PFAS exposure and introduces a shared, net-present-value framework under the companies' existing US$4.00 billion cost-sharing cap. The North Carolina deal follows Chemours' June 2026 agreement with the U.S. EPA, which added US$90 million of PFAS mitigation and a US$22.5 million civil penalty, as well as settlements with New Jersey and a water district. Chemours' narrative projects $6.6 billion in revenue and $686.0 million in earnings by 2029, requiring 4.7% yearly revenue growth and a $990.0 million earnings increase from -$304.0 million today, with a $19.78 fair value implying 37% upside. The most pessimistic analysts assume only about 3.3% annual revenue growth and roughly US$556 million of earnings by 2029.

Impact on stocks 3

Critical Materials & Supply Chain▲ · 1 stocks
Chemours Co
CC
▲ PositiveRegulationrelevance

Settles North Carolina PFAS claims for $455M, clearing a significant portion of its legacy PFAS exposure under the existing cost-sharing cap.

Synthetic Biology (non-pharma)▲ · 1 stocks
Corteva Inc
CTVA
▲ PositiveRegulationrelevance

Corteva is party to the $455M North Carolina PFAS settlement, resolving claims within the companies' shared $4.00B cost-sharing framework.

Climate Adaptation & Water▲ · 1 stocks
Dupont De Nemours Inc
DD
▲ PositiveRegulationrelevance

DuPont is party to the $455M North Carolina PFAS settlement, resolving legacy contamination claims under the shared cost-sharing cap.

© 2026 MarketDXNews